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significantly higher in comparison with the control group of patients (by 2.1, 1.4-and 4.9 
times, respectively). Similar results were observed when comparing Jevels of neopterin, 
TNFa and CRP in patients with IHD with hypothyroidism with a group of patients with IHD 
without structural and functional changes in thyroid gland: their concentration was by 
2.2; 1.3 and 3.1 times higher than the corresponding indicators, respectively (p <0.05). This 
indicates a clear immune activation in patients with IHD in the context of concomitant 
hypothyroidism. The question of the relationship between markers of immune activation, 
inflammation and endothelial dysfunction in patients with IHD with thyroid pathology 
is also an interesting one. Significant positive correlation relationships were established 
between the level of neopterin and TSH (r=+0.36; p <0.05), ET-1 and TSH (r=+0.46; p 
<0.05) and inverse correlation interactions between the neopterin level concentration 
and free T4 (r=-0.29; p <0.05). The obtained data testify that hypothyroidism increases 
the risk of complications of atherosclerosis, provokes the progression of IHD both due to 
the development of endothelial dysfunction, stimulation of systemic inflammation and 
increased secretion of proinflammatory cytokines [4]. Thus, patients with IHD, which 
occurs on the background of hyperthyroidism, had an increase in markers of immune 
activation and endothelial dysfunction compared with patients with IHD without thyroid 
disease. The presence of correlations between the levels of neopterin and ET-1 with the 
hormones of the pituitary-thyroid system suggests the involvement of hypothyroidism in 
stimulating systemic inflammation and the development of endothelial dysfunction in 
patients with IHD.
Prospects for further research: Further scientific research will deal with the 
development of optimally substantiated schemes of differentiated combined treatment 
of patients with IHD on the background of hypothyroidism, taking into account changes 
in immune-inflammatory and endothelium dysfunction markers.
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INHIBITION OF MARKERS OF THE IMMUNE INFLAMMATION IN BRONCHIAL
ASTHMA INFLUENCED BY FULLERENE C60 NANOPMATERIALS
Mamontova T.V., Vesnina L.E., Kaidashv  I . P.
Ukrainian Medical Stomatological Academy, Ukraine
Bronchial asthma (BA) is a chronic disease associated with local tissue inflammation 
anc! remodeling of the airway [1, 2]. Inflammation is a complex immune response 
which involves immune cells as regulators and effectors of the immune function and, 
therefore, may play critical role in pathophysiological processes. Recent studies have 
suggested the possible effect of dysfunction immune cells and/or their products 
on inflammation process in BA. Fullerene C60 is the most promising nanomaterial in
modern medicine due its key properties, small size, enhanced permeability, surface 
modification and retention effect [3, 4]. Fullerene C60 and some of its derivatives 
as potent antioxidants are capable of effective ROS inactivation and lack of 
immunogenicity [5, 6]. However, little is known about the effect of fullerene C60 on 
immune mechanisms in the pathogenesis of BA. Therefore, further studies of fullerene 
C60will be required for the development of specialized target treatment strategy in 
BA. The purpose of our work was to determine the effect of fullerene C60 on markers 
of immune inflammation in experimental model of BA.
Materials and Methods. Balb/c 24 mice aged 6 weeks were divided into 4 groups: 
intact, control and two experimental. Experimental BA sensitization of mice were induced 
by the ovalbumin (OVA; Sigma, USA) intraperitoneal solution in a sterile physiological 
saline at the start of the study and at day 14, and by inhalation of the OVA solution at 24, 
25, and 26 days. Animals of the experimental groups were intraperitoneally injected with 
an aqueous dispersion of fullerene C60 or a fullerene C60 solution conjugated with OVA 
in an amount of 0.05 ml at 24, 25, 26 days, one hour before OVA inhalation. Evaluated 
the level of CD4 + and CD8 + lymphocytes by flow cytometry, cellular composition in 
the lungs by the method of tissue imprints, histological analysis was conducted light 
microscopy (Axio Lab.Al, Carl Zeiss, Germany).
Results. CD4+T lymphocytes expression was significantly increased to 38.5 ± 1.05% 
and CD8+ T lymphocytes expression was significantly decreased to 21.2 ± 1.2% in mouse 
with experimental BA compared to intact group. After administration of fullerene C60 
CD4+T lymphocyte expression was significantly reduced to 30.83 ± 0.6% compared to 
animals with BA. After administration of fullerene C60 conjugated with OVA only CD8+ T 
lymphocyte expression was significantly increased compared to animals with BA.
In the study of lung tissue imprints in animals with experimental BA, eosinophils and 
lymphocytes quantity were increased, while neutrophils and alveolar macrophages 
quantity were significantly decreased in the lung. After administration of fullerene C60 
and its conjugated to OVA form macrophages quantity were significantly increased 
in the lumen of the airways compared to animals with BA. A morphological study of 
large and medium-sized bronchi in animals with experimental BA revealed that there 
are areas with goblet cell hyperplasia, an increased number of cells, dystrophy and 
atrophy of the epithelium. Marked infiltration of the submucosa and muscie plate by 
mononuclear cells (lymphocytes) was revealed. Various forms of fulierenes contributed 
to the normalization of the state of tissue structure. The bronchial epithelium is 
predominantly cylindrical, a decrease in bronchial secretion was noted. The lumen of 
the bronchioles and bronchi were free. A decrease in infiltration by mononuclear cells 
v/as noted.
Conclusions. These results suggest that fullerene C60 effectively prevents immune 
inflammation in a mouse model of BA by decreasing the level of CD4 +T lymphocytes 
expression and the number of eosinophils, increasing the number of neutrophils and 
macrophages as celis of non-specific immune protection. Fullerene C60 significantly 
decreases tissue inflammation and airway remodeling. In conclusion, fullerene C60 
acts as potential anti-inflammatory and immunomodulatory agent via inhibition of 
NF-kB- and MARK-dependent signaling pathways [7] and, therefore, may prevent 
inflammatory responses during BA.
Prospects for further research. Further studies are needed to characterize the 
effects of nanoparticle-based drugs on the prevention of immune inflammation and 
the development of a treatment strategy for bronchial asthma.
Recommendations. Markers of immune inflammation are an important goal in 
the study of the pathogenetic course of AD. Our results lay the foundation for further 
study on the use of fullerene C60 as an anti-inflammatory agent in the treatment of 
bronchial asthma.
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NEUTROPHILIC EXTRACELLULAR TRAPS IN TISSUES WITH DIFFERENT 
TREATMENT MODES OF COLORECTAL CANCER
Maratkyzy M.
Department of Oncology and Radiology, Karaganda Medical University, Republic of Kazakhstan
An important feature of malignant tumors is their relatively autonomous growth, 
regulated by locally produced factors, which include “microenvironment factors” 
of tumors produced by both the tumor cells themselves and the cells of the stroma 
surrounding them. A permanent component in the structure of microenvironment 
of tumors are neutrophilic granulocytes. But their role in oncogenesis is not fully 
established. There is evidence that in addition to antitumor activity neutrophils can 
demonstrate antitumor activity, provoking metastasis. In response to microbial and non- 
microbial stimuli, neutrophils actively form network-like structures in the extracellular 
space consisting of nucleic acids and enzymes -  neutrophil extracellular traps (NET). 
Fibrous structures of NET represent the main DNA chain containing histones and proteins 
-  products of neutrophil granules. The main protective function is the destruction of 
pathogens [1]. Views about the role of neutrophil traps in Oncology vary greatly. On 
the one hand, there is evidence of anticarcinogenic properties of NET associated with 
direct destruction of tumor cells and stimulation of fhe immune system. Cytotoxicity 
in relation to tumor cells is manifested by the components of NET (myeloperoxidase, 
proteinase and histones), while DNA strands are considered as a kind of tool for 
capturing tumor cells and limiting their further spread [2, 3]. On the other hand, NET 
can promote migration and immune avoidance of tumor cells. The possible role of the 
flow of neoplastic process As a prognostic biomarker in NET is suggested [4, 5]. The aim 
of this study was to investigate extracellular neutrophii traps in colorectal cancer.
Materials and Methods. The study is carried out within the framework of fhe scientific 
and. technical program “Personalized approach in the management of a number 
of significant diseases”, developed by the NAO “Medical University of Karaganda”. 
A set of patients with cancer of the colon and rectum was carried out under the 
conditions of the KGP “Regional Oncology center” of Karaganda, Kazakhstan. 
The clinical diagnosis was established according to ICD 10, for fhe classification of
